Arbet-Engels Christophe
- SEC CIK
- 0001802615
No open-market purchases or sales filed in the past year.
Current role at each company
- ALT Altimmune, Inc.Chief Medical Officeras of Oct 3, 2025
- XFOR X4 Pharmaceuticals, IncChief Medical Officeras of Feb 14, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Arbet-Engels Christophe as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XFOR X4 Pharmaceuticals, Inc
Chief Medical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 (view filing)6:15 PM ET | Jan 24 | 3 days | Arbet-Engels ChristopheChief Medical Officer | SSale | −11.6K | $0.4546 | −$5.28K | −45.0%14.2K after |